-
1
The Association of Serum Lactoferrin Level with Psychological Symptoms, Cognition, and Executive Function in Schizophrenia Patients
Published 2024-12-01Subjects: Get full text
Article -
2
Reducing maladaptive behavior in neuropsychiatric disorders using network modification
Published 2025-01-01Subjects: Get full text
Article -
3
-
4
Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system
Published 2025-01-01Subjects: Get full text
Article -
5
Parasite in the brain: the role of Toxoplasma gondii in brain cancer and neuropsychiatric disorders
Published 2024-12-01Subjects: Get full text
Article -
6
Humour Runs through the Multicoloured Mosaic of Neuropsychotherapy: Scoping Review
Published 2024-12-01Subjects: Get full text
Article -
7
Neuropsychiatric profile in tuberous sclerosis complex patients with epilepsy
Published 2025-01-01Subjects: Get full text
Article -
8
-
9
Gut mycobiome and neuropsychiatric disorders: insights and therapeutic potential
Published 2025-01-01Subjects: Get full text
Article -
10
Pituitary adenylate cyclase-activating polypeptide plays a role in neuropsychiatric and substance use disorders: sex-specific perspective
Published 2025-02-01Subjects: “…neuropsychiatric disorders…”
Get full text
Article -
11
-
12
Potential common targets of music therapy intervention in neuropsychiatric disorders: the prefrontal cortex-hippocampus -amygdala circuit (a review)
Published 2025-02-01Subjects: “…neuropsychiatric disorders…”
Get full text
Article -
13
From Serendipity to Precision: Integrating AI, Multi-Omics, and Human-Specific Models for Personalized Neuropsychiatric Care
Published 2025-01-01Subjects: Get full text
Article -
14
IUPHAR Review: Alpha6-containing GABAA receptors – Novel targets for the treatment of schizophrenia
Published 2025-03-01Subjects: Get full text
Article